Peter Blume-Jensen, President & CEO, Director at Acrivon Therapeutics, Inc., holds 2.62M shares in Acrivon Therapeutics, Inc. (Ticker: ACRV). Most recently, Peter Blume-Jensen Sold 14,036 shares of Acrivon Therapeutics, Inc. on Aug 27, 2026 for an estimated value of $30.88K.
What is the percentage of profitable transactions made by Peter Blume-Jensen?
The percentage of profitable transactions made by Peter Blume-Jensen is 100%.
What is the average return per transaction made by Peter Blume-Jensen?
The average return per transaction made by Peter Blume-Jensen is 5.00%.
What stocks does Peter Blume-Jensen hold?
Peter Blume-Jensen holds: ACRV stocks.
What was Peter Blume-Jensen’s latest transaction?
Peter Blume-Jensen latest transaction was an Informative Sell of $30.88K.
What was Peter Blume-Jensen's most profitable transaction?
Peter Blume-Jensen’s most profitable transaction was an Informative Buy of ACRV stock on January 16, 2026. The return on the trade was 11.10%.
What is Peter Blume-Jensen's role in Acrivon Therapeutics, Inc.?
Peter Blume-Jensen's role in Acrivon Therapeutics, Inc. is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.